Efficacy and Tolerability of MLC601 in Patients With Mild to Moderate Alzheimer Disease Who Were Unable to Tolerate or Failed to Benefit From Treatment With Rivastigmine
Clinical trial NCT01696123 · COMPLETED
Trial details
- NCT number
- NCT01696123
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2012-01-01
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.